Kimbo Slice Ken Shamrock Steroid

Kimbo Slice Tests Positive For Steroid, Ken Shamrock Tests Positive For Steroid And Opioid

Published On March 22, 2016 | MMA News
Share post on...Share on FacebookTweet about this on TwitterPin on PinterestShare on StumbleUponEmail this to someone

MMA Junkie – Ken Shamrock and Kevin “Kimbo Slice” Ferguson tested positive for the same steroid following their appearances at Bellator 149 this past month.

Shamrock (28-17-2 MMA, 0-2 BMMA), 52, and Slice (6-2 MMA, 2-0 BMMA), 42, were found with the steroid nandrolone, according to urine test results released by the Texas Department of Licensing and Regulation, which oversees the Texas Combative Sports program that oversaw the Feb. 19 event at Houston’s Toyota Center.

Shamrock also tested positive for methadone, a synthetic opioid used to treat heroin addicts, following his first-round TKO loss to Royce Gracie in the event’s Spike-televised headliner.

Shamrock and Slice each face up to a one-year suspension and $5,000 fine. The TDLR is offering the fighters a settlement – good until March 31 – for “coming into compliance” that offers a reduced punishment of a $3,000 and a license revocation, records show. Compliance equates to the fighters explaining their side of the story to the commission, TDLR Susan Stanford told MMAjunkie.

You are telling me two old guys with chiseled bodies still competing in mixed martial arts are using steroids? I don’t believe it. I think the test results must be wrong because you don’t get crazy unnatural muscle gains by being unnatural. I think Kimbo and Ken are like a bottle of Henri Jayer Richebourg Grand Cru…they get better with age. I know you are impressed with my knowledge of expensive wines but you shouldn’t be. I am cultured and way better than you. I can afford the finer things in life. I am not some scrub that has a champagne taste on a beer budget. If I want to drink 32 mimosas, I will drink 32 mimosas. As for Shamrock and Slice…innocent until proven guilty!!!

Share post on...Share on FacebookTweet about this on TwitterPin on PinterestShare on StumbleUponEmail this to someone

Comments are closed.